Republic of Korea excels in Burkitt's lymphoma treatment, with top hospitals like Severance Hospital, Samsung Medical Center, and Asan Medical Center. Accredited by the Joint Commission International, they offer advanced therapies such as CAR T-cell therapy, autologous stem cell transplantation, and IGRT. Severance Hospital treats 1.6 million outpatients annually, while Samsung Medical Center utilizes the Novalis radiosurgery and Da Vinci systems.
Asan Medical Center, Korea's largest multidisciplinary center, boasts organ transplant success rates up to 90%. Its oncology commitment attracts many international patients. Korea's Burkitt's lymphoma treatment emphasizes personalized medicine and cutting-edge technology, significantly improving survival rates. For more statistics, see the study.